A 12-week clinical trial found something unexpected: when people with Crohn's disease simply shifted when they ate—compressing all meals into an 8-hour window instead of spreading them across the day—their disease activity dropped by 40% and abdominal pain was cut in half. They didn't eat less. They didn't eat differently. They just ate on a tighter schedule.
Twenty participants followed time-restricted feeding while 15 continued eating normally. The results went beyond symptom relief. Those on the restricted schedule lost weight, showed healthier inflammation markers, and developed more favorable gut bacteria—even though calorie intake stayed roughly the same. "We saw meaningful improvements in disease symptoms, reduced abdominal discomfort, favorable shifts in metabolism and inflammation," said Dr. Maitreyi Raman, the study's senior author at the University of Calgary. "All suggesting that intermittent fasting may help patients maintain lasting remission."
The mechanism appears biological rather than behavioral. Participants in the intermittent fasting group experienced a significant reduction in visceral fat—the harmful kind that accumulates around organs—and key inflammatory signals in the bloodstream. Because both groups ate similar foods in comparable amounts, the improvements weren't simply about better diet quality or eating fewer calories. The timing itself seemed to matter.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxThis matters because Crohn's disease, an inflammatory bowel condition affecting roughly 780,000 Americans, often leaves people searching for practical tools to pair with medication. Time-restricted eating—consuming everything within an 8-hour daily window and fasting for 16 hours—offers something accessible and grounded in how the body actually works. "People with Crohn's disease often look for practical tools to support their health alongside medication," said Dr. Natasha Haskey, the study's lead investigator. "Our research suggests time-restricted eating may be a sustainable option."
Researchers are careful about the scale of their claims. The trial included 35 adults with Crohn's disease and obesity or overweight—a specific group. Larger, longer studies are needed to understand whether these benefits hold across different populations and whether they last. But the foundation is there: a low-cost, medication-free intervention that appears to reset how the digestive and immune systems respond.
The research was funded through the Crohn's & Colitis Foundation's Litwin IBD Pioneers program, part of a broader shift toward understanding how everyday behaviors—not just drugs—can reshape inflammatory disease.
